Apoptosis of tumor-infiltrating T lymphocytes: a new immune checkpoint mechanism

Immunotherapy based on checkpoint inhibitors is providing substantial clinical benefit, but only to a minority of cancer patients. The current priority is to understand why the majority of patients fail to respond. Besides T-cell dysfunction, T-cell apoptosis was reported in several recent studies a...

詳細記述

書誌詳細
主要な著者: Zhu, J, Petit, P, Van Den Eynde, B
フォーマット: Journal article
言語:English
出版事項: Springer Berlin Heidelberg 2018

類似資料